Vericel Corp
Nasdaq · Biological Products, (No Diagnostic Substances)
Company Overview
A concise company profile alongside the latest public filing activity.
Vericel Corp develops and markets cell therapy products for sports medicine and severe burn care, including treatments for cartilage repair in the knee and skin grafts for burn patients.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| ZERBE ROBERT L MDDirector | Sell | $114K | 2,500at $45.40 | Nov 4, 2026 |
| ZERBE ROBERT L MDDirector | Sell | $28K | 500at $55.00 | Nov 5, 2026 |
| ZERBE ROBERT L MDDirector | Sell | $129K | 2,500at $51.67 | Nov 5, 2026 |
| Flynn Sean C.Chief Legal Officer | Sell | $779K | 15,000at $51.92 | Nov 5, 2026 |
| SIEGAL JONATHANPrincipal Accounting Officer | Sell | $79K | 1,500at $52.90 | Nov 5, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable VCEL activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.